Skip to main content
Article
Abstract 4652: Cerebrospinal fluid pharmacokinetics and pharmacodynamics following high-dose erlotinib treatment in brain cancer patients
Cancer Research (2014)
  • Sandra Pastorino, University of California, San Diego
  • Sandeep C. Pingle, University of California, San Diego
  • Emma Langley, 2Prometheus Therapeutics & Diagnostics, San Diego, CA;
  • Phillip Kim, 2Prometheus Therapeutics & Diagnostics, San Diego, CA;
  • Tiffany Juarez, University of California, San Diego
  • Pengfei Jiang, University of California, San Diego
  • Christopher Tucker, OSI Pharmaceuticals
  • Txheng Yang, OSI Pharmaceuticals
  • Marlon Saria, University of California, San Diego
  • Sharat Singh, 2Prometheus Therapeutics & Diagnostics, San Diego, CA;
  • Santosh Kesari, University of California, San Diego
Publication Date
October 1, 2014
DOI
10.1158/1538-7445.AM2014-4652
Citation Information
Sandra Pastorino, Sandeep C. Pingle, Emma Langley, Phillip Kim, et al.. "Abstract 4652: Cerebrospinal fluid pharmacokinetics and pharmacodynamics following high-dose erlotinib treatment in brain cancer patients" Cancer Research Vol. 74 (2014) p. 4652 - 4652
Available at: http://works.bepress.com/marlon-saria/29/